Difficulty: Medium
Average Score: 66%
Practice
Dopamine at medium doses influences mainly:
Correct answer
C
Rationale
The correct answer is C) Beta-1 adrenoreceptors (leads to enhanced cardiac output).
Dopamine at medium doses primarily influences Beta-1 adrenoreceptors, found in the heart. Stimulation of these receptors results in increased contractility and heart rate, leading to enhanced cardiac output. This is a key mechanism of action for using dopamine in conditions like heart failure or shock where increasing cardiac output is beneficial.
Option A, Alpha-adrenoreceptors, is incorrect because dopamine at medium doses does not significantly affect these receptors to cause peripheral vasoconstriction.
Option B, Dopamine receptors leading to vasodilation of renal and mesenteric vessels, is incorrect because dopamine at medium doses primarily acts on adrenergic receptors, not dopamine receptors, to exert its effects on the cardiovascular system.
Option D, All of the above, is incorrect as explained above. Understanding the specific receptor targets of dopamine at different doses is crucial for the appropriate use of this medication in clinical practice.
In an educational context, this question highlights the importance of understanding pharmacological mechanisms of action to make informed clinical decisions. It also underscores the significance of dose-dependent effects of medications and how they can have varying impacts on different receptor systems within the body. This knowledge is essential for healthcare professionals involved in prescribing and administering pharmacological treatments across different age groups.
Dopamine at medium doses primarily influences Beta-1 adrenoreceptors, found in the heart. Stimulation of these receptors results in increased contractility and heart rate, leading to enhanced cardiac output. This is a key mechanism of action for using dopamine in conditions like heart failure or shock where increasing cardiac output is beneficial.
Option A, Alpha-adrenoreceptors, is incorrect because dopamine at medium doses does not significantly affect these receptors to cause peripheral vasoconstriction.
Option B, Dopamine receptors leading to vasodilation of renal and mesenteric vessels, is incorrect because dopamine at medium doses primarily acts on adrenergic receptors, not dopamine receptors, to exert its effects on the cardiovascular system.
Option D, All of the above, is incorrect as explained above. Understanding the specific receptor targets of dopamine at different doses is crucial for the appropriate use of this medication in clinical practice.
In an educational context, this question highlights the importance of understanding pharmacological mechanisms of action to make informed clinical decisions. It also underscores the significance of dose-dependent effects of medications and how they can have varying impacts on different receptor systems within the body. This knowledge is essential for healthcare professionals involved in prescribing and administering pharmacological treatments across different age groups.